Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Brighton Biotech
AddedFeb 16, 2024
UpdatedJun 18, 2026
Brighton Biotech

Brighton Biotech

Public

US-based Brighton Biotech manufactures pharmaceutical and biotech drugs for human and veterinary use.

HQ
Fort Worth, TX, US
Founded
2010
Overview
Compare
Fundraising
Employees

Brighton Biotech is a US-based pharmaceutical and biotechnology company focused on manufacturing drugs for human and veterinary use. Their mission is to advance healthcare through innovative drug development and production, targeting both human and animal health markets.

Brighton Biotech has made significant strides in the pharmaceutical industry, contributing to advancements in drug manufacturing and processing. Their impact is reflected in their commitment to improving global health outcomes through high-quality pharmaceutical solutions.

Brighton Biotech - Similar Companies

BiotechInnova logo

BiotechInnova

biotechinnova.com

Bright Path Laboratories logo

Bright Path Laboratories

brightpathlabs.com

Amerigen Pharmaceuticals logo

Amerigen Pharmaceuticals

amerigenpharma.com

Gradient Pharmaceuticals logo

Gradient Pharmaceuticals

EIR Pharmaceuticals logo

EIR Pharmaceuticals

Blended BioHealth logo

Blended BioHealth

Bionpharma logo

Bionpharma

bionpharma.com

Goldfinch Bio logo

Goldfinch Bio

BridGene Biosciences logo

BridGene Biosciences

ISI Life Sciences logo

ISI Life Sciences

Elixir Bio-Tech logo

Elixir Bio-Tech

Rjs Biologics logo

Rjs Biologics

Sinogen Biopharma logo

Sinogen Biopharma

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Brighton Biotech - Quick Facts

Who are Brighton Biotech's competitors?

Companies similar to Brighton Biotech include BiotechInnova, Bright Path Laboratories, Amerigen Pharmaceuticals and Gradient Pharmaceuticals.

When was Brighton Biotech founded?

Brighton Biotech was founded in 2010.

Where is Brighton Biotech's headquarters located?

Brighton Biotech's headquarters is located in Fort Worth, TX, US.

When was Brighton Biotech's last funding round?

Brighton Biotech's most recent funding round was for $1.6M (USD) in November 2014.

How much has Brighton Biotech raised to-date?

As of Nov 18, 2014, Brighton Biotech has raised a total of $1.6M (USD).

How many employees does Brighton Biotech have?

Brighton Biotech has 5 employees as of Feb 5, 2024.

Brighton Biotech - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Biotech Drugs
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified